Guidelines are evidence filtered through opinion. The opinion is crucial - but whose opinion should it be?
I saw this in an article and found it VERY fitting for so many of the discussions we share here on HU.
Many times we see people regurgitating clinical trials on HU like they are the end-all-be-all gospel for everyone to use. Every man who is XXXXX state of disease gets XX treatment.
But what we see over time is using that kind of ego is like recommending "standardized care" for every prostate cancer patient that has X state of disease. I think we can support this detriment with all of the treatment failures discussed on this platform.
Guidelines and clinical trials are just "evidence filtered through opinion" is what I see. And many times we see updates and changes to clinical trial protocols as they develop.
I bounced out of the STAMPEDE protocol at 24 months of leuprolide and 18 months of abiraterone vs the 36 months. This wasn't just something on a whim but after a discussion with my MO who felt that the difference between 24 vs 36 months may be a single digit percentage of difference of benefit.
Was I guaranteed a cure at 36 months and I forfeited that opportunity? Or was my uPSA of < .006 for over 12 months with adt and so far 7 months post adt truly indicating sufficient treatment? Will I have durable remission? If, so for how long?
What's the empirical evidence showing I have made the right or wrong choice?
Did my RO allow me to make the wrong choice?
I just really appreciated this statement and found it fitting for those of us who walk in the shoes of advanced disease and/or recurrent disease.